- Fukuda K, Straus SE, Hickie I et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953- 9.
- National Institute of Allergy and Infectious Diseases, Chronic Fatigue Syndrome for Physicians. NIH publication no. 96-484.
- Calabrese LH, Daneo T, Camara EG, Wilke WS. Chronic fatigue and immune dysfunction . Cleve Clin J Med 1992; 59(2): 123-4.
- Levy JA. Viral studies of chronic fatigue syndrome. Clin Infect Dis 1994; 18 (Suppl. 1): S117-20.
- Ojo-Amaze EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue dysfunction syndrome. Clin Infect Dis 1994; 18 (Suppl. 1): S157-9.
- Barker E, Fugimura SF, Fadem MB et al. Immunological abnormalities associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18: 5136-41.
- Suhadolnik RJ, Reichenbach NL, Hitzges P et al. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18 (Suppl. 1): S96-104.
- Ben-Efraim S, Keisari Y, Ophir R et al. Immunopotentiating and immunotherapeutic effects of thymic hormones and factors with special emphasis on thymic humoral factor THF-Y2. Crit Rev Immunol 1999; 19: 261-84.
- Beardsley TR, Pierschbacher MP, Wetzel GD, Hays EF. Induction of T cell maturation by a cloned line of thymic epithelium (TEPI). Proc Natl Acad Sci 1993; 80: 6005-9.
- Hays E, Beardsley TR. Immunologic effects of human thymic stromal grafts and cell lines. Clin Immunol Immunopathol 1984; 33: 381-91.
- Wells HG. Studies on the chemistry of anaphylaxis III: experiments with isolated proteins, especially those of the hens egg. J Infect Dis 1911; 9: 147-53.
- Castell JV, Friedrich G, Kuhn CS, Poppe GE. Intestinal absorption of undegraded protein in men: presence of bromelain in plasma after oral intake. Am J Physiol 1997; 237: G139-46.
- Fanta C, Bohle B, Hirt W, Siemann U et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999; 12: 218-24.
- Homann D, Dyrberg T, Petersen J et al. Insulin in oral "tolerance": a one-amino acid change in the B chain makes the difference. J Immunol 1999; 163: 1833-8.
- Vojdani A, Choppa PC, Lapp CW. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A Synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome. J Clin Lab Immunol 1998; 50: 1-16.
- Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer receptor repertoire. Ann Rev Immunol 2001; 19: 291-330.
- Vojdani A, Lapp CW. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacol Immunotoxicol 1999; 21: 175-202.
- Nicolson GL, Nicolson NL. Diagnosis and treatment of mycoplasmal infections in Persian Gulf War illness and CFIDS patients. Int J Occup Med Immunol Toxicol 1996; 5: 69-78.
- Nicholson GL, Nasralla MY, Franco AR. Role of mycoplasma infections in fatigue illness: chronic fatigue, . bromyalgia syndromes , Gulf War illness and rheumatoid arthritis. J Chronic Fatigue Syndrome 2000; 6: 23-39.
- Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991; 338: 708-12.
- Carfdin RD, Brooks JW, Sarawar SR, Doherty PC. Progressive loss of CD81 T cell-mediated control of a gamma herpesvirus in the absence of CD41 T cells. J Exp Med 1996; 184(3): 863-71.
- Riordan NH, Jackson JA. Pilot study of the effects of thymus protein on elevated Epstein-Barr virus titers. Townsend Newsletter for Doctors and Patients 1998; Feb/Mar: 78-9.
- Golderberg DL. Fibromyalgia and its relation to chronic fatigue syndrome. Viral illness and immune abnormalities . J Rheumatol 1989; 19 (Suppl.): 91-3.
- Lerner AM, Zeruos M, Chaung CH, Beqaj S. A small randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome. Clin Infect Dis 2001; 32(11): 1657-8.
Improved Immune Activation Markers in Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Patients Treated with Thymic Protein A
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.